DNA Sequencing-Based Monitoring of Minimal Residual Disease to Predict Clinical Relapse in Aggressive B-cell Non-Hodgkin Lymphomas
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Ryvu Therapeutics SA
Sanofi
Weill Medical College of Cornell University
Novartis
M.D. Anderson Cancer Center
Stanford University
Ohio State University Comprehensive Cancer Center
University of Colorado, Denver
Bezmialem Vakif University
Fred Hutchinson Cancer Center
National Institutes of Health Clinical Center (CC)
Arbeitsgemeinschaft medikamentoese Tumortherapie